Hypercalcemia due to parathyroid hormone-related protein produced by primary ovarian clear cell adenocarcinoma: Case report

被引:16
作者
Tsunematsu, R
Saito, T
Iguchi, H
Fukuda, T
Tsukamoto, N
机构
[1] Kyushu Natl Canc Ctr, Gynecol Serv, Minami Ku, Fukuoka 8111395, Japan
[2] Kyushu Natl Canc Ctr, Dept Biochem, Minami Ku, Fukuoka 8111395, Japan
[3] Kyushu Natl Canc Ctr, Dept Pathol, Minami Ku, Fukuoka 8111395, Japan
关键词
ovarian cancer; clear cell adenocarcinoma; hypercalcemia; parathyroid hormone-related protein; incadronate;
D O I
10.1006/gyno.1999.5619
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Among ovarian carcinomas, clear cell adenocarcinoma is one of the most common histologic subtypes associated with hypercalcemia. However, the mechanisms of hypercalcemia in clear cell adenocarcinoma are still unclear. In the following case report, we tried to determine the etiology of hypercalcemia and also to demonstrate the management of hypercalcemia diagnosed preoperatively. Case. A 49-year-old woman was diagnosed as having a malignant ovarian tumor with hypercalcemia caused by elevated serum parathyroid hormone-related protein (PTHrP) prior to her primary surgery. Treatment with disodium incadronate promptly normalized the serum calcium level. An immunohistochemical study demonstrated PTHrP expression in the primary ovarian lesion, but not in the metastatic lesion. A Northern blot analysis of the cancer cells from the ovarian tumor confirmed the presence of PTHrP mRNA, Conclusion. Humoral hypercalcemia of malignancy in this case has been conclusively shown to be due to the production of PTHrP at the primary ovarian tumor, based on both immunohistochemical and molecular analyses. (C) 2000 Academic Press.
引用
收藏
页码:218 / 222
页数:5
相关论文
共 13 条
  • [1] PARATHYROID-HORMONE RELATED PROTEIN AND HYPERCALCEMIA IN BREAST-CANCER
    BUNDRED, NJ
    RATCLIFFE, WA
    WALKER, RA
    COLEY, S
    MORRISON, JM
    RATCLIFFE, JG
    [J]. BRITISH MEDICAL JOURNAL, 1991, 303 (6816) : 1506 - 1509
  • [2] FUJINO T, 1992, CANCER-AM CANCER SOC, V70, P2845, DOI 10.1002/1097-0142(19921215)70:12<2845::AID-CNCR2820701221>3.0.CO
  • [3] 2-F
  • [4] Holtz G, 1980, Obstet Gynecol Surv, V35, P129, DOI 10.1097/00006254-198003000-00001
  • [5] In situ detection of parathyroid hormone-related protein in ovarian clear cell carcinoma
    Kitazawa, R
    Kitazawa, S
    Matui, T
    Maeda, S
    [J]. HUMAN PATHOLOGY, 1997, 28 (03) : 379 - 382
  • [6] MATIASGUIU X, 1994, CANCER, V73, P1878, DOI 10.1002/1097-0142(19940401)73:7<1878::AID-CNCR2820730717>3.0.CO
  • [7] 2-D
  • [8] Rogers MJ, 1997, CANCER, V80, P1652, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1652::AID-CNCR15>3.0.CO
  • [9] 2-Z
  • [10] SUVA LJ, 1987, SCIENCE, V237, P894